Dedicated to the Safe, Clinically Effective and Globally Accessible CAR & TCR Based Cell Therapies in Oncology & Beyond
The 6th CAR-TCR Summit will return in 2021 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world.
Bringing together CAR and TCR experts from pharma, biotech and academia, this unique platform will provide you with unrivaled networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. Delving into the pioneering developments from early discovery through to late-stage commercialization, this is 4 days your team cannot afford to miss!
Introducing the 2021 Scientific Advisory Board
Adrian Bot
Global Head Translational Medicine
Kite: A Gilead Company
Adrienne Farid
CDO
Century Therapeutics
Axel Hoos
SVP, R&D Governance Chair & Therapeutic Area Head Oncology
GSK
Barbra Sasu
CSO
Allogene
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy
Perelman School of Medicine
Bob Valamehr
CDO
Fate Therapeutics
Dolores Schendel
CEO & CSO
Medigene
Gregory Fiore
CEO
Exacis
Margo Roberts
Krishnan Viswanadhan
SVP, Global Cell Therapy Franchise Lead
Bristol Myers Squibb
“To support the CAR-TCR Summit in its role at the forefront of the industry, providing a progressive end-to-end forum, we have shared our expertise to shape the agenda into a truly ‘don’t miss’ event”
CAR-TCR Scientific Advisory Board
"An impactful event that is a must-do for anyone working on CAR-TCR therapies."
![HW190321_CART_Slider_designs[1] testimonial GE](https://car-tcr-summit.com/wp-content/uploads/sites/71/2019/06/HW190321_CART_Slider_designs1-testimonial-GE-1.jpg "HW190321_CART_Slider_designs[1] testimonial GE")
Lead Partner
Proud to Partner With:
2020 Industry Partners
Other Events in the CAR-TCR Series
As part of the CAR-TCR Series, we are running events in Asia and in Europe. Please visit the individual event pages for more information.
February, 2022
May 4-6, 2021
Digital Event
October, 2021
November 2022